Virtual screening of epalrestat mimicking selective ALR2 inhibitors from natural product database: auto pharmacophore, ADMET prediction and molecular dynamics approach
- PMID: 33480327
- DOI: 10.1080/07391102.2021.1875878
Virtual screening of epalrestat mimicking selective ALR2 inhibitors from natural product database: auto pharmacophore, ADMET prediction and molecular dynamics approach
Abstract
Epalrestat is the only effective aldose reductase (ALR2) inhibitor available in the market for the treatment of diabetic neuropathy. Clinical effectiveness of epalrestat in diabetic neuropathy encouraged us to develop some more ALR2 inhibitors with a better therapeutic profile. Herein, we utilized the pharmacophoric features of epalrestat to search some novel ALR2 inhibitors from an InterBioScreen database of natural compounds. ADME and PAINS filters were applied to provide drug-likeness and to remove toxicophores from the screened hits. The pharmacophoric features of 4-hydroxy-2-nonenal (HNE), a well-known substrate of ALR1, were also explored to identify selective ALR2 inhibitors. The structure-based analysis was then adopted to find out the molecules showing interactions with ALR2 which are crucial for their therapeutic activity. These interaction patterns and binding modes were compared with that of epalrestat. Molecular dynamics (MD) analysis was also carried out to get more insight into the interactions of screened hits in the catalytic domain of ALR2. Additionally, the top hits were docked and simulated with aldehyde reductase (ALR1) to determine their selectivity for ALR2 over ALR1. Overall, five hits including STOCKIN-44771, STOCKIN-46041, STOCKIN-59369, STOCKIN-69620 and STOCKIN-88220 were found to possess a good therapeutic profile in terms of key interactions, binding energies and drug-likeness. Two hits, STOCKIN-46041 and STOCKIN-59369, were identified as the most selective ALR2 inhibitors when assessed their selectivity profile.Communicated by Ramaswamy H. Sarma.
Keywords: ALR2; Epalrestat; InterBioScreen database; auto-pharmacophore; diabetic complications; molecular dynamics.
Similar articles
-
Pharmacophore derived 3D-QSAR, molecular docking, and simulation studies of quinoxaline derivatives as ALR2 inhibitors.J Biomol Struct Dyn. 2024;42(19):10452-10488. doi: 10.1080/07391102.2023.2256885. Epub 2023 Sep 12. J Biomol Struct Dyn. 2024. PMID: 37698364
-
Search for non-acidic ALR2 inhibitors: Evaluation of flavones as targeted agents for the management of diabetic complications.Bioorg Chem. 2020 Mar;96:103570. doi: 10.1016/j.bioorg.2020.103570. Epub 2020 Jan 11. Bioorg Chem. 2020. PMID: 31978681
-
QM/MM analysis, synthesis and biological evaluation of epalrestat based mutual-prodrugs for diabetic neuropathy and nephropathy.Bioorg Chem. 2021 Mar;108:104556. doi: 10.1016/j.bioorg.2020.104556. Epub 2020 Dec 15. Bioorg Chem. 2021. PMID: 33376013
-
Addressing selectivity issues of aldose reductase 2 inhibitors for the management of diabetic complications.Future Med Chem. 2020 Jul;12(14):1327-1358. doi: 10.4155/fmc-2020-0032. Epub 2020 Jun 30. Future Med Chem. 2020. PMID: 32602375 Review.
-
Epalrestat: an aldose reductase inhibitor for the treatment of diabetic neuropathy.Pharmacotherapy. 2008 May;28(5):646-55. doi: 10.1592/phco.28.5.646. Pharmacotherapy. 2008. PMID: 18447661 Review.
Cited by
-
Novel role for epalrestat: protecting against NLRP3 inflammasome-driven NASH by targeting aldose reductase.J Transl Med. 2023 Oct 7;21(1):700. doi: 10.1186/s12967-023-04380-4. J Transl Med. 2023. PMID: 37805545 Free PMC article.
-
Repurposing of epalrestat for neuroprotection in parkinson's disease via activation of the KEAP1/Nrf2 pathway.J Neuroinflammation. 2025 Apr 29;22(1):125. doi: 10.1186/s12974-025-03455-x. J Neuroinflammation. 2025. PMID: 40301912 Free PMC article.
-
Identification of Putative Plant-Based ALR-2 Inhibitors to Treat Diabetic Peripheral Neuropathy.Curr Issues Mol Biol. 2022 Jun 29;44(7):2825-2841. doi: 10.3390/cimb44070194. Curr Issues Mol Biol. 2022. PMID: 35877418 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials